Arxis Inc (ARXS) Stock Forecast & Price Target

Arxis is supported by a differentiated industrial-compounding model that combines proprietary, mission-critical electronic and mechanical components with strong pricing power, evidenced by 17% organic growth in 1Q26 and 21% in 2Q26 alongside ~42% margins. Its outlook is further strengthened by disciplined M&A execution since the 2026 IPO, including five acquisitions and the $770M Omnetics deal, which management expects to add about $59M of revenue in 2026 and ~$113M in 2027. With net debt of $1.2B and 1.8x net leverage after 2Q26, the company appears well capitalized to pursue additional deals, while its Arcline partnership and ability to double acquired EBITDA in 3–5 years support durable upside.

Arxis is facing a negative outlook because its growth relies heavily on defense sales, OEM ramp timing, and aircraft delivery cycles, all of which are exposed to political and execution risk. The downside cases show that a slowdown could reduce revenue CAGR to 12%, 9%, or even 7.5% through 2028, with sales falling to $2.25B, $2.1B, or $2.0B and adj. EBITDA slipping to about $880M, $814M, or $770M despite margins near 38% to 39%. Limited long-term agreement coverage of only 10%-15% of revenue, around 5% annual business roll-off, and uncertainty around M&A integration and defense appropriations further weaken earnings durability and support the bearish stance.